| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 08/04/2004 | CN1518446A Repinotan kit |
| 08/04/2004 | CN1160351C Process for preparation of thiazolidinedione derivatives |
| 08/04/2004 | CN1160343C Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 08/04/2004 | CN1160341C Substituted 2,4-diamino-1,3,5-triazines |
| 08/04/2004 | CN1160071C Use of substiuted 2,4-imidazolidinedione compounds as analgesics |
| 08/03/2004 | US6770667 N-((imidazolyl)-phenyl)-fluorene-1-carboxamide derivatives; 5-hydroxytryptamine (5-ht) antagonists; psychological, nervous system, eating, brain and sleep disorders |
| 08/03/2004 | US6770666 Fused-ring compounds and use thereof as drugs |
| 08/03/2004 | US6770663 Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds |
| 08/03/2004 | US6770638 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 08/03/2004 | US6770637 Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors |
| 08/03/2004 | US6770627 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p 53 |
| 07/29/2004 | WO2004063194A1 Heteroaryl compounds |
| 07/29/2004 | WO2004063193A1 4-{`3-(sulfonylamino) phenyl! `1-(cyclymethyl) piperidin-4-ylidene! methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder |
| 07/29/2004 | WO2004063190A1 Fused heterocyclic derivates as ppar modulators |
| 07/29/2004 | WO2004063179A1 Substituted arylcyclopropylacetamides as glucokinase activators |
| 07/29/2004 | WO2004063171A1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache |
| 07/29/2004 | WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | WO2004063157A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/29/2004 | WO2004063155A1 Fused heterocyclic derivatives as ppar modulators |
| 07/29/2004 | WO2004062667A1 Amorphous form of rosiglitazone maleate and process for preparation thereof |
| 07/29/2004 | WO2004062664A1 Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders |
| 07/29/2004 | WO2004062663A1 Use of substituted 2-phenylbenzimidazoles as medicaments |
| 07/29/2004 | WO2004062613A2 Hiv integrase inhibitors |
| 07/29/2004 | WO2004062562A2 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/29/2004 | WO2004062361A2 Spiro compounds |
| 07/29/2004 | WO2004050030A3 Anti-sickling agents |
| 07/29/2004 | WO2004050024A3 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 07/29/2004 | WO2004041777A3 Heteroarylpiperidine modulators of chemokine receptor activity |
| 07/29/2004 | WO2004031401A3 Novel tyrosine kinases inhibitors |
| 07/29/2004 | WO2004021997A8 Inhibitors of fungal invasion |
| 07/29/2004 | WO2004014868A8 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 07/29/2004 | WO2004013091A3 4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases |
| 07/29/2004 | WO2003094861A3 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 07/29/2004 | WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 07/29/2004 | US20040147760 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| 07/29/2004 | US20040147752 Carbazole derivatives for the treatment of NPY related diseases |
| 07/29/2004 | US20040147748 Increasing insulin secretion; type II diabetes; such as 2-(3-Chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-(5-methylsulfanyl-pyrazin-2-yl)-propionamide |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147739 Novel anti-infectives |
| 07/29/2004 | US20040147596 Antidiabetic agents; immunology diseases; antiinflammatory agents |
| 07/29/2004 | US20040147576 Cardiovascular disorders; thrombosis; anticoagulants |
| 07/29/2004 | US20040147574 Antagonist of transforming growth factor; antiproliferative agents |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147572 Novel pyrrolyl-thiazole derivatives |
| 07/29/2004 | US20040147561 Pyrid-2-one derivatives and methods of use |
| 07/29/2004 | US20040147560 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 07/29/2004 | US20040147557 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/29/2004 | US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147555 Anticoagulants; brain disorders; blood circulation disorders; myocardial infraction |
| 07/29/2004 | US20040147553 Efficiency; side effect reduction; antiarthriutic agents; autoimmune diseases |
| 07/29/2004 | US20040147535 Endothelial growth factor; angiogenesis inhibitor; antitumor agents; skin disorders; endometriosis; Crohn's disease ; leukemia; antiarthritic agents |
| 07/29/2004 | US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 07/29/2004 | US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists |
| 07/29/2004 | US20040147518 4-[3-(3-chloro-6-methoxyquinolin-4-yl)propyl]-1-[2-(thien-2-yl)thioethyl]piperidine-4-carboxylic acid or salt for example; antibacterial activity |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147502 Beta lactam compounds and their use as inhibitors of tryptase |
| 07/29/2004 | US20040147401 2-aryl thiazole derivatives as KCNQ modulators |
| 07/29/2004 | US20040146955 CA IX-specific inhibitors |
| 07/29/2004 | US20040146554 Providing an active pharmaceutical compound; providing a basic salt as one of a powder, a suspension and a solution having a pH greater than 7; combining; delivering the non-enteric coated liquid formulation |
| 07/29/2004 | US20040146438 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 07/29/2004 | US20040143911 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye |
| 07/29/2004 | DE10301519A1 New substituted 9-keto-spinosyn derivatives, useful for control of animal pests and microorganisms, in plant protection and veterinary medicine, also new intermediates |
| 07/29/2004 | DE10301419A1 Spiroverbindungen Spiro compounds |
| 07/29/2004 | CA2513132A1 New carboxylic acids and the esters thereof, pharmaceutical compositions containing these compounds and processes for the preparation thereof |
| 07/29/2004 | CA2512813A1 Use of substituted 2-phenylbenzimidazoles as phamaceutical compositions |
| 07/29/2004 | CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | CA2511818A1 Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders |
| 07/29/2004 | CA2510516A1 Fused heterocyclic derivatives as ppar modulators |
| 07/29/2004 | CA2510400A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/29/2004 | CA2510382A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/29/2004 | CA2509202A1 Fused heterocyclic derivatives as ppar modulators |
| 07/28/2004 | EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/28/2004 | EP1440973A2 Epothilone derivatives, preparation and use |
| 07/28/2004 | EP1440070A1 4-(5-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 07/28/2004 | EP1440069A1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 07/28/2004 | EP1440068A1 Acyl dihydro pyrrole derivatives as hcv inhibitors |
| 07/28/2004 | EP1440066A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 07/28/2004 | EP1440060A1 4(piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 07/28/2004 | EP1439834A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/28/2004 | EP1140862A4 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/28/2004 | EP0805816B1 Compounds with growth hormone releasing properties |
| 07/28/2004 | CN1516696A Halogen compounds having thrombopoietin receptor agonism |
| 07/28/2004 | CN1516695A Arylsulfonamides as antiviral agents |
| 07/28/2004 | CN1516693A Benzimidazoles that are useful in treating sexual dysfunction |
| 07/28/2004 | CN1516691A Phenylpyridine carbonyl piperazine derivative |
| 07/28/2004 | CN1516587A Quinazoline derivatives capable of promoting release of parathyroid |
| 07/28/2004 | CN1515259A 4-aminosubstituted-2-substituted-1,2,3,4-tetrahydroquinoline used as CETP inhibitor |
| 07/28/2004 | CN1159318C Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/28/2004 | CN1159314C Thiazolidinedione derivs. as antidiabetic agents |
| 07/28/2004 | CN1159311C Dihydropyrimidines |
| 07/28/2004 | CN1159305C Novel 2-(N-cyanoimino) thiazolidin-4-one derivatives |
| 07/28/2004 | CN1159303C Preparation of intermediate for monocyclic beta-lactams antibiotic derivatives |
| 07/28/2004 | CN1159292C Aryl substitued cyclic amines as selective dopamine D3 ligands |
| 07/27/2004 | US6768008 For therapy |
| 07/27/2004 | US6767915 Substituted piperidines as melanocortin receptor agonists |
| 07/27/2004 | US6767912 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/27/2004 | US6767864 Pesticides, herbicides |
| 07/27/2004 | CA2320233C Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 07/24/2004 | WO2003059904A1 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 07/22/2004 | WO2004061084A2 Modulation of protein functionalities |